{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:10:35Z","timestamp":1767859835622,"version":"3.49.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>\n                           <jats:sup>68<\/jats:sup>Ga-Pentixafor is a novel radiotracer for imaging chemokine receptor subtype 4 (CXCR4) receptors, which are expressed exceptionally high in several hematologic malignancies, including various types of lymphoma. Herein we report a case of a 64-year-old man patient with suspected hematologic malignancy who underwent <jats:sup>18<\/jats:sup>F-FDG and <jats:sup>68<\/jats:sup>Ga-pentixafor PET\/CT. Both scans demonstrated diffusely increased activity related to bone marrow involvement. <jats:sup>68<\/jats:sup>Ga-Pentixafor PET\/CT demonstrated CXCR4-expressing intra-abdominal lymph nodes that were not detected by <jats:sup>18<\/jats:sup>F-FDG PET\/CT. The patient was highly suspicious of lymphoma; however, histopathological examination of the bone marrow revealed systemic mastocytosis with associated myelofibrosis.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003817","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T15:12:19Z","timestamp":1626448339000},"page":"e563-e564","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["CXCR4 Expression Demonstrated by 68Ga-Pentixafor PET\/CT Imaging in a Case of Systemic Mastocytosis Mimicking Lymphoma"],"prefix":"10.1097","volume":"46","author":[{"given":"Murat Yilmaz","family":"Kiran","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evsen","family":"Apaydin Arikan","sequence":"additional","affiliation":[{"name":"Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasemin","family":"Sanli","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulcin","family":"Yegen","sequence":"additional","affiliation":[{"name":"Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serkan","family":"Kuyumcu","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s12149-017-1196-x","article-title":"Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of 18FDG-PET\/CT according to \u0394SUVmax, Deauville 5-point scale and IHP criteria","volume":"31","year":"2017","journal-title":"Ann Nucl Med"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2214\/ajr.179.5.1791235","article-title":"FDG positron emission tomography in patients with systemic mastocytosis","volume":"179","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/RLU.0b013e3181638e5e","article-title":"Imaging of systemic mastocytosis by FDG-PET\/CT demonstrates increased activity in cortical bone","volume":"33","year":"2008","journal-title":"Clin Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.rlu.0000178029.47624.66","article-title":"Myelofibrosis on F-18 FDG PET imaging","volume":"30","year":"2005","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc1388","article-title":"Cancer and the chemokine network","volume":"4","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2967\/jnumed.111.098798","article-title":"PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent","volume":"52","year":"2011","journal-title":"J Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/RLU.0000000000002166","article-title":"Imaging of chemokine receptor CXCR4 in mycosis fungoides using 68Ga-pentixafor PET\/CT","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"77S","DOI":"10.2967\/jnumed.116.186874","article-title":"CXCR4 ligands: the next big hit?","volume":"58","year":"2017","journal-title":"J Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.leukres.2007.04.008","article-title":"Distinct clonal origins of systemic mastocytosis and associated B-cell lymphoma","volume":"31","year":"2007","journal-title":"Leuk Res"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:04:59Z","timestamp":1750536299000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003817","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,15]]}}}